Suchen Sie nach Informationen zu Hauptsitz Von Alnylam Pharmaceuticals? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


Alnylam® Pharmaceuticals

    https://www.alnylam.com/
    Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hyperoxaluria, and porphyria. Skip to main content Our Company. About Alnylam; …

Contact Alnylam® Pharmaceuticals

    https://www.alnylam.com/contact-us
    Alnylam Pharmaceuticals, Inc – Corporate Headquarters. 675 West Kendall St Cambridge, MA 02142 USA Tel: 617.551.8200 Fax: 617.551.8101. Alnylam UK Ltd. Braywick Gate Braywick Rd …

Alnylam Pharmaceuticals - Wikipedia

    https://en.wikipedia.org/wiki/Alnylam_Pharmaceuticals
    none

Alnylam Pharmaceuticals, Inc. Company Profile

    https://www.dnb.com/business-directory/company-profiles.alnylam_pharmaceuticals_inc.d5844cf7458ecf126248dd78ec6b8e44.html
    Find company research, competitor information, contact details & financial data for Alnylam Pharmaceuticals, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.

Alnylam Pharmaceuticals, Inc. Company Profile - Dun

    https://www.dnb.com/business-directory/company-profiles.alnylam_pharmaceuticals_inc.f77aeac5497827e6196179962b069807.html
    Company Description: Like a genetic linebacker, Alnylam Pharmaceuticals runs interference with RNA to prevent the forward progress of disease. RNA interference (RNAi) technology …

Alnylam Pharmaceuticals Company Profile - Craft

    https://craft.co/alnylam-pharmaceuticals
    Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for …

Investor Relations | Alnylam Pharmaceuticals, Inc.

    https://investors.alnylam.com/
    The Investor Relations website contains information about Alnylam Pharmaceuticals, Inc.'s business for shareholders, potential investors, and financial analysts.

ALNYLAM PHARMACEUTICALS, INC. - MarketScreener.com

    https://www.marketscreener.com/quote/stock/ALNYLAM-PHARMACEUTICALS-8322/company/
    Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It is developing therapeutics based on ribonucleic acid interference (RNAi). Its pipeline includes four products …

Alnylam Pharmaceuticals, Inc.: Alnylam erhält positive CHMP ...

    https://www.finanznachrichten.de/nachrichten-2022-07/56623727-alnylam-pharmaceuticals-inc-alnylam-erhaelt-positive-chmp-stellungnahme-zu-vutrisiran-fuer-die-behandlung-der-hereditaeren-transthyretin-vermittelten-004.htm
    2 days ago · Alnylam hat seinen Hauptsitz in in Cambridge, US-Bundesstaat Massachusetts. ... Hinweis von Alnylam zu zukunftsgerichteten Aussagen. ... Alnylam Pharmaceuticals, Inc. …

Alnylam Pharmaceuticals Inc - Company Profile and …

    https://www.bloomberg.com/profile/company/ALNY:US
    Company profile page for Alnylam Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Alnylam Pharmaceuticals gefunden haben.